Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 29, 1993
Glycosylation of CD4 and Thy-1R A Dwek, D A Ashford, C J Edge, et al.
British Journal of Anaesthesia|May 25, 2019
Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in miceRita Campos-Pires, Tobias Hirnet, Flavia Valeo, et al.
Transplantation|September 25, 2020
Pro-IL-1β Is an Early Prognostic Indicator of Severe Donor Lung Injury During Ex Vivo Lung PerfusionTriin Major, Alexandra L Ball, John P Stone, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 9, 2015
A multi-country Salmonella Enteritidis phage type 14b outbreak associated with eggs from a German producer: 'near real-time' application of whole genome sequencing and food chain investigations, United Kingdom, May to September 2014T Inns, C Lane, T Peters, et al.
Plos Neglected Tropical Diseases|August 4, 2025
Preclinical evaluation of the neutralising efficacy of three antivenoms against the venoms of the recently taxonomically partitioned E. ocellatus and E. romaniRebecca J Edge, Amy E Marriott, Molly Keen, et al.
Nature Chemical Biology|September 24, 2013
A propofol binding site on mammalian GABAA receptors identified by photolabelingGrace M S Yip, Zi-Wei Chen, Christopher J Edge, et al.
Toxicon: X|September 16, 2024
Plug and play virus-like particles for the generation of anti-toxin antibodiesRebecca J Edge, Amy E Marriott, Emma L Stars, et al.
Biological Psychiatry|November 28, 2006
Relationship of movements and behaviors to Group A Streptococcus infections in elementary school childrenTanya K Murphy, Lisa A Snider, P Jane Mutch, et al.
Toxicon: X|March 24, 2022
<i>In vitro</i> and <i>in vivo</i> preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by <i>Dispholidus typus</i>Stefanie K Menzies, Rachel H Clare, Chunfang Xie, et al.
Toxins|July 25, 2022
Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite AntivenomsNessrin Alomran, Patricia Blundell, Jaffer Alsolaiss, et al.
Pageof 12